Fred Alger Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-17,320
| Closed | -$796K | – | 462 |
|
|
2024
Q3 | $796K | Buy |
17,320
+1,695
| +11% | +$77.9K | ﹤0.01% | 356 |
|
|
2024
Q2 | $638K | Buy |
+15,625
| New | +$638K | ﹤0.01% | 367 |
|
|
2023
Q3 | – | Sell |
-131,649
| Closed | -$1.46M | – | 523 |
|
|
2023
Q2 | $1.46M | Sell |
131,649
-26,244
| -17% | -$291K | 0.01% | 358 |
|
|
2023
Q1 | $2.42M | Sell |
157,893
-18,256
| -10% | -$280K | 0.01% | 321 |
|
|
2022
Q4 | $3.91M | Buy |
+176,149
| New | +$3.91M | 0.02% | 284 |
|
|
2022
Q1 | – | Sell |
-107,326
| Closed | -$2.55M | – | 549 |
|
|
2021
Q4 | $2.55M | Buy |
107,326
+12,521
| +13% | +$298K | 0.01% | 347 |
|
|
2021
Q3 | $2.34M | Buy |
+94,805
| New | +$2.34M | 0.01% | 341 |
|
|
2020
Q4 | – | Sell |
-16,243
| Closed | -$457K | – | 501 |
|
|
2020
Q3 | $457K | Sell |
16,243
-3,757
| -19% | -$106K | ﹤0.01% | 382 |
|
|
2020
Q2 | $565K | Buy |
+20,000
| New | +$565K | ﹤0.01% | 391 |
|